PREVALENCE OF HEPATITIS C AMONGST HIGH-RISK GROUPS AND PATIENTS IN A TERTIARY CARE CENTER IN CENTRAL KERALA AND THEIR CLINICO-HEMATOLOGICAL PROFILE.

Dr Maria John, Dr Seema Oommen, Ozhiparambil Anilkumar Jagan, Sincy George, Dr Sivan Pillai

Abstract


Hepatitis C is a positive stranded RNA virus, which belongs to the
family Flaviviridae.It was rst identied in the late 1970’s as a separate
disease causing post-transfusion hepatitis and was initially termed as
non-A non-B hepatitis.


Keywords


Hepatitis Chronic Hepatitis rightly common chronic blood borne infections

Full Text:

PDF

References


Perz JF, Armstrong GL, Farrington LA, Hutin YJ BB. The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. J Hepatology 2006; 45: 529-538 5. J Hepatol. 2006;45(529–538).

Antwerp B. WHO. Global surveillance and control of hepatitis C. Report of a WHO Consultation organized in collaboration with the Viral Hepatitis Prevention Board, Antwerp, Belgium. J Viral Hepat 1999;635–47. 1999;6:35–47.

Alter MJ. Epidemiology of hepatitis C virus infection. World J Gastroenterol 2007. 2007;13(17):2436–41.

S C. Hepatitis C. A major health problem of India. Curr Sci 2002;83:9. Curr Sci. 2002;83:9.

Di Bisceglie AM, Order SE KJ et al. The role of chronic viral hepatitis in hepatocellular carcinoma in the United States. Am J Gas- troenterol 1991; 86: 335–33. Am J Gas- troenterology. 1991;86:335–33.

Lavanchy D, Ticino M. Evolving epidemiology of hepatitis C virus. 2011;

Mandell B and D. Principles and Practices of Infectious Diseases. 7th ed.

Vermunt J, Fraser M, Herbison P, Wiles A, Schlup M, Schultz M, et al. Prevalence and knowledge of hepatitis C in a middle-aged population , Dunedin , New Zealand. 2015;21(35):10224–33.

Pawlotsky, J. M., L. Taskiris, F. Roudot-Thoraval, C. Pellet, L. Stuyver, J.Duval and DD. Relationship between hepatitis C virusgenotypes and sources of infection in patients with chronic hepatitis C. J.Infect. Dis. 171:1607–1610. JInfect. 1995;(171):1607–10.

El-wahab EWABD, Mikheal A, Sidkey F. Factors Associated with Hepatitis C Infection among Chronic HCV Egyptian Patients. 2014;43(11):1510–8.

Guidelines EASL Recommendations on Treatment of Hepatitis C 2015. 2015;63:199–236.

Morishima C GD. Clinical use of Hepatitis C virus test for the diagnosis and monitoring during therapy. Clin Liver Dis. 1999;3:717–40. Clin Liver Dis. 1999;3:717–40.

Cox AL , Netski DM MT et al. .Prospective evaluation of community acquired acute phase hepatitis C viris infection.Clin.Infect Dis 2005: 40: 951-958. ClinInfect Dis. 2005;40:951–8.

Reddy A K MKV and L V. Prevalence of HCV infection in patients on haemodialysis: survey by antibody and core antigen detection; Indian J. Med. Microbiol. 23 106–110. Indian J Med Microbiol. 2005;23:106–10.

Zampieron A, Jayasekera H, Elseviers M, Lindley E, De Vos JY, Visser R HM. European study on epidemiology and the management of HCV in the haemodialysis population—Part 1:centre policy. EDTNA ERCA J. 2004; 30(2):84-90). EDTNA ERCA J. 2004;30(2):84–90.

Garcia-Montalvo BM, Galguera-Colorado PL. Distribution of hepatitis C virus genotypes, risk factors and liver disease in patients from Yucatan, Mexico. Ann Hepatol. 2008;7(4):345–9.

Malhotra P, Malhotra V, Malhotra N, Singh I, Chugh A, Chaturvedi A. Epidemiological Profile of Hepatitis C Patients at India ’ s New Hub – Haryana. 2015;1(1).

Hauri AM, Armstrong GL HY. . The global burden of disease attributable to contaminated injections given in health care settings. Int J STD AIDS 2004; 15: 7-16). Int J STD AIDS. 2004;15:7–16.

(Alter MJ, Kruszon-Moran D, Nainan OV, McQuillan GM, Gao F, Moyer LA, Kaslow RA MH. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med 1999; 341:556-62). 1 N Engl J Med 1999; 341556-62). 1994;341:556–62.

N T. Sexual activity as a risk factor for Hepatitis C.(Hepatology 2002 :36 S99- 105. (Hepatology. 2002;36:99–105.

Mukhopadhya A. Hepatitis C in India. Journal of Biosciences. 2008. p. 465–73.

Ustündag Y, Bilezikçi B, Boyacioğlu S, Kayataş M ON. The utility of AST/ALT ratio as a non- invasive demonstration of the degree of liver fibrosis in chronic HCV patients on long-term haemodialysis. Nephrol Dial Transplant 2000;15:1716-7. Nephrol Dial Transpl. 2000;15:1716–7.


Refbacks

  • There are currently no refbacks.